Tag - avacopan

Latest ISN Journal Editorial Selections

Kidney International® Executive Summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis Since the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) Guideline for the Management of Glomerular Diseases was published, important data concerning anti-neutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) has become available. These include the regulatory approval of avacopan for ANCA-AAV...